Chronic hepatitis B with flare due to co-infection of hepatitis delta virus during lamivudine therapy

Internal Medicine

Volumn 42, Issue 7, 2003, Pages 581-586

  Joh, Riho ^a   Hasegawa, Kiyoshi ^a   Tokushige, Katsutoshi ^a   Hashimoto, Etsuko ^a   Torii, Nobuyuki ^a   Yamashiro, Takeshi ^b   Enomoto, Nobuyuki ^b   Watanabe, Mamoru ^b   Hayashi, Naoaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

HBV; HDV; Lamivudine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; NEOMINOPHAGEN C; VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; DISEASE EXACERBATION; DNA SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HISTOPATHOLOGY; HOMOSEXUALITY; HOSPITAL ADMISSION; HUMAN; LIVER DISEASE; MALE; MIXED INFECTION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TREATMENT OUTCOME;

EID: 0041670938     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.581     Document Type: Article

References (21)

1. Severini A, Liu XY, Wilson JS, Tyrrell DL. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-b-L-2′,3′-dideoxy-3′-thiacytidine. Antimicrob Agents Chemother 39: 1430-1435, 1995.
2. Nevens F, Main J, Honkoop P, et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose ranging study. Gastroenterology 113: 1258-1263, 1997.
3. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24: 714-717, 1996.
4. Honkoop P, Niesters HG, de Man RA, Osterhaus AD, Schalm SW. Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. J Hepatol 26: 1393-1395, 1997.
5. Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24: 711-713, 1996.
6. Rizzetto M. The delta agent. Hepatology 3: 729-737, 1983.
7. Ackerman Z, Valinluck B, McHutchison JG, Redeker AG, Govindarajan S. Spontaneous exacerbation of disease activity in patients with chronic delta hepatitis infection: the role of hepatitis B, C or D? Hepatology 16: 625-629, 1992.
8. Hadziyannis SJ, Sherman M, Lieberman HM, Shaftitz DA. Liver disease activity and hepatitis B virus replication in chronic delta antigen positive hepatitis B virus carriers. Hepatology 5: 544-547, 1985.
9. Lau DT-Y, Doo E, Park Y, et al. Lamivudine for chronic delta hepatitis. Hepatology 30: 546-549, 1999.
10. Hasegawa K, Hashimoto E, Kanai N, et al. Living-related partial liver transplantation for decompensated hepatitis B without reactivation of hepatitis B in the following 30 months. J Gastroenterol 36: 637-642, 2001.
11. Omori K, Hasegawa K, Ogawa M, et al. Small-bowel hemorrhage caused by cytomegalovirus vasculitis following fulminant hepatitis. J Gastroenterol 37: 954-960, 2002.
12. Ogawa M, Hasegawa K, Naritomi T, Torii N, Hayashi N. Clinical features and viral sequences of various genotypes of compared among patients with acute hepatitis B. Hepatol Res 23: 167-177, 2002.
13. Kobayashi M, Arase Y, Ikeda K, et al. Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C. J Gastroenterol 37: 35-39, 2002.
14. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus. Large-scale analysis using a new genotyping method. J Infect Dis 175: 1285-1293, 1997.
15. Dienstag JL, Schiff ER, Mitchell M, et al. Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy. Hepatology 30: 1082-1087, 1999.
16. Leon P, Lopez JA, Contreras G, Echevarria JM. Antibodies to hepatitis delta virus in intravenous drug addicts and male homosexuals in Spain. Europ J Clin Microbiol Infect Dis 7: 533-535, 1988.
17. Sakugawa H, Nakasone H, Kawakami Y, et al. Determination of hepatitis delta virus (HDV)-RNA in asymptomatic cases of HDV infection. Am J Gastroenterol 92: 2232-2236, 1997.
18. Jenna S, Sureau C. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus. Virology 251: 176-186, 1998.
19. Lau DT, Kleiner DE, Park Y, Di Bisceglie AM, Hoofnagle JH. Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. Gastroenterology 117: 1229-1233, 1999.
20. Wolters LMM, van Nunen AB, Honkoop P, et al. Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. J Viral Hepat 7: 428-434, 2000.
21. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. The complete nucleotide sequences of the cloned hepatitis B virus DNA: subtype adr and adw. Nucleic Acids Res 11: 1747-1757, 1983.